India Inc investment plans add up to Rs 1,75,629 Cr. : ASSOCHAM
India is set to become a potential goldmine as investment announcements surged to Rs.1,75,629 crore for months of August and September 2007 says the ASSOCHAM Eco Pulse Study.
Dishman Pharmaceuticals acquires Dutch chemicals firm
Gujarat-based Dishman Pharmaceuticals and Chemicals Ltd has signed a deal with Dutch company Solvay Pharmaceuticals to acquire its fine chemicals, vitamin D and vitamin D analogues businesses.
4th India Health Summit –CII
Dr. Prathap Reddy, Chairman, CII National Committee on Healthcare & Chairman, Apollo Hospitals Group, aims to create 'Health India' brand to put India in the global healthcare map in the forthcoming 4th India health Summit
AJANTA Q2 NET UP 31%
Ajanta Pharma Limited Net Profit grew by 31% to Rs.2.81 crores (Rs.2.14 crores) for the second quarter ended 30th September, 2007
US court rules in favour of Bayer over Avelox patents
US court ruled in favour of Bayer the German drugs and chemicals maker, in a case in Dr Reddy's Laboratories had challenged the validity of two US patents for antibiotic Avelox.
Pfizer to develop and market Taisho’s schizophrenia drug
Pfizer Inc announced that the company has signed a letter of intent for the development and commercialization with Taisho Pharmaceutical Co
Novartis invest US$700m in Singapore
Novartis is investing US$700 million to build a new large-scale biotechnology facility in Singapore
BioAlliance presents the results of its New Entity – AMEP at ESGCT
BioAlliance Pharma presents research results for a new cancer therapy agent at the 15th congress of the European Society of Gene and Cell Therapy, Rotterdam, October 27-30.
The Centre plans to set up EPZs for traditional medicines
The Centre has proposed to set up export processing zones for traditional Indian medicines in partnership with private entrepreneurs to boost overseas sales of ethnic herbs, which stood at Rs 900 crore in 2006-07.
Genzyme launches Cholestagel in Europe
Genzyme Corp. has launched it’s first commercially available cardiovascular product Cholestagel (colesevelam hydrochloride), in Europe.
India & China share in global market has doubled : KPMG
India and China, share of emerging markets in the global pharmaceutical industry has more than doubled to $32 billion in 2006 from $15 billion in 2001 according to KPMG report
SCM Logistics Middle East 2007
SCM Logistics Middle East 2007 – the region's definitive conference for supply chain professionals in the manufacturing industry to be held at the Shangri-la Hotel, Dubai on 29 and 30 October 2007.
Small drug units form new association – SPIC
Small scale manufacturers of non-exempt states is coming together to form a new association called SME Pharma Industries Confederation (SPIC)
Ranbaxy launches osonase nasal spray
Ranbaxy has launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial and seasonal allergies
Glenmark signs marketing agreement with MeyerZall
Glenmark Pharmaceuticals’s its South African arm has signed a 10-year marketing and distribution rights agreement with MeyerZall Laboratories that will help in expanding its topical dermatology portfolio.
European Commission wants new IP protection layer
The European Commission wants to create a new layer of intellectual property protections because it says existing structures such as WIPO are not flexible enough.
Sanaria to set up new Malaria Vaccine Plant soon
Biotechnology company Sanaria, Rockville, plans to open a new malaria vaccine plant that was funded partially by a $29.3 million grant from the Bill & Melinda Gates Foundation and $3.5 million in federal small business grants
Bioinformatics market to grow at over 16%
Bioinformatics has made its place in the laboratory and R&D departments of every country, but US is leading the worldwide bioinformatics market finds out RNCOS in its recent research report
Almirall in agreement to acquire products from Shire
Spain-based Laboratorios Almirall has entered into a definitive agreement to acquire a portfolio of eight products from Shire for $213m (€151m)
Cipla gets tentative nod from USFDA for granisetron HCL
Cipla Ltd has received tentative approval from the U.S. Food and Drug Administration for granisetron hydrochloride tablets